Medicines Patent Pool signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of ViiV Healthcare’s innovative long-acting HIV prevention medicine
The Pharma Data
MARCH 31, 2023
This is enabled by the signing of a voluntary licensing agreement for patents relating to cabotegravir LA for PrEP with MPP in July 2022. Trademarks are owned by or licensed to the ViiV Healthcare group of companies. According to UNAIDS’ latest estimates, approximately 1.5 Please see full US Prescribing Information for Apretude.
Let's personalize your content